HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffith, B. P. Articles by Williams, P. Search for Related Content PubMed PubMed Citation Articles by Griffith, B. P. Articles by Williams, P.

The Annals of Thoracic Surgery, Vol 54, 846-851, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Acute rejection of lung allografts with various immunosuppressive protocols

BP Griffith, RL Hardesty, JM Armitage, RL Kormos, GC Marrone, S Duncan, I Paradis, JH Dauber, SA Yousem and P Williams
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15261.

Between February 1990 and December 1991, 69 patients who survived for a minimum of 5 days after single-lung (27), double-lung (32), or heart- lung transplantation (10) were studied to learn the incidence and severity of acute rejection and the possible effects of various immunosuppressive protocols on this rejection. Acute rejection was less common (2.1 versus 3.1 episodes/patient) after transplantation in those 30 candidates who received rabbit antithymocyte globulin for the first 5 postoperative days versus the 28 who were maintained on cyclosporine, azathioprine, and prednisone alone (p < 0.05), but no patient escaped at least one episode. Patients given cyclosporine received more 3-day courses of methylprednisolone (p < 0.02) than those given rabbit antithymocyte globulin (2.5 versus 1.7 courses). Although no disadvantage in terms of infectious morbidity was noted in the rabbit antithymocyte globulin group, no obvious intermediate advantage was noted in survival (85% at 12 months) or grade of rejection or airway flows. The most common histopathologic grades were mild (A2) and moderate (A3); the average grade was A2.3. FK 506 was tested in 11 patients, and early results are promising relative to low early and likely fewer late episodes of rejection. No differences were noted in the likelihood of rejection for any procedures.

This article has been cited by other articles:

				C. Knoop, A. Haverich, and S. Fischer Immunosuppressive therapy after human lung transplantation Eur. Respir. J., January 1, 2004; 23(1): 159 - 171. [Abstract] [Full Text] [PDF]

				A. Pereszlenyi, G. Lang, H. Steltzer, H. Hetz, A. Kocher, P. Neuhauser, W. Wisser, and W. Klepetko Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 858 - 863. [Abstract] [Full Text] [PDF]

				S. M. Palmer, A. P. Miralles, C. M. Lawrence, J. W. Gaynor, R. D. Davis, and V. F. Tapson Rabbit Antithymocyte Globulin Decreases Acute Rejection After Lung Transplantation: Results of a Randomized, Prospective Study Chest, July 1, 1999; 116(1): 127 - 133. [Abstract] [Full Text] [PDF]

				S. N. Mitruka, S. M. Pham, A. Zeevi, S. Li, J. Cai, G. J. Burckart, S. A. Yousem, R. J. Keenan, and B. P. Griffith Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 28 - 37. [Abstract] [Full Text] [PDF]

				R. J. Keenan, A. Iacono, J. H. Dauber, A. Zeevi, S. A. Yousem, N. P. Ohori, G. J. Burckart, A. Kawai, G. C. Smaldone, and B. P. Griffith TREATMENT OF REFRACTORY ACUTE ALLOGRAFT REJECTION WITH AEROSOLIZED CYCLOSPORINE IN LUNG TRANSPLANT RECIPIENTS J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 335 - 341. [Abstract] [Full Text]

				R. J. Novick, H.-J. Schafers, L. Stitt, B. Andreassian, J.-P. Duchatelle, W. Klepetko, R. L. Hardesty, A. Frost, and G. A. Patterson RECURRENCE OF OBLITERATIVE BRONCHIOLITIS AND DETERMINANTS OF OUTCOME IN 139 PULMONARY RETRANSPLANT RECIPIENTS J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1402 - 1414. [Abstract] [Full Text]

				R. M. Bolman III Advantage-FK 506: Reduced Chronic Rejection for Lung Transplant Recipients Ann. Thorac. Surg., September 1, 1995; 60(3): 495 - 496. [Full Text]

				Diagnostic and Therapeutic Technology Assessment (DATTA) JAMA, February 17, 1993; 269(7): 931 - 936. [PDF]